Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Treatment Resistant Depression
NCT04732169Phase 4Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cannabidiol in major depressive disorder (MDD), sponsored by University of Alabama at Birmingham. Planned start Jul 2021; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04732169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04732169.